Go Pro
NYSEAMERICAN:CITR

CitroTech Q1 2025 Earnings Report

CitroTech logo
$5.25 -0.03 (-0.57%)
As of 03:21 PM Eastern

CitroTech EPS Results

Actual EPS
-$0.23
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

CitroTech Revenue Results

Actual Revenue
$0.97 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

CitroTech Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Tuesday, May 20, 2025
Conference Call Time
8:00AM ET

Earnings Documents

CitroTech Earnings Headlines

FDA Momentum is Building Around NNVC!
NanoViricides (NYSE: NNVC) just received regulatory approval to begin a Phase II trial of NV-387 Oral Gummies for Ebola in the DRC, now the country's largest outbreak on record with over 4,100 cases. NV-387 uses a host-mimetic nanoviricide platform designed to trap and neutralize viruses. Noble Capital Markets recently initiated coverage on NNVC with an Outperform rating and a $6 price target.tc pixel
See More CitroTech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CitroTech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CitroTech and other key companies, straight to your email.

About CitroTech

CitroTech (NYSEAMERICAN:CITR) manufactures and sells fire inhibitor products in the United States and Canada. The company also offers lumber treatment and spraying solutions, as well as develops wildfire defense systems on residential and commercial properties under the CitroSafe Systems brand name. It serves wildland fire, residential home protection, wood products, ground application, lumber and building materials, and construction industries; homeowners; governments; and agencies. The company was formerly known as General Enterprise Ventures, Inc. and changed its name to CitroTech Inc. in January 2026. The company is based in Greenwood Village, Colorado.

 

View CitroTech Profile